Mirati Therapeutics (MRTX) PT Lowered to $209 at JPMorgan, Following Earnings

May 7, 2021 12:27 PM EDT Send to a Friend

JPMorgan analyst Anupam Rama lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Mirati Therapeutics (MRTX) PT Lowered to $209 at JPMorgan, Following Earnings

Member Login

Free News Feed